← All trials
NCT01715922
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2012
- Primary completion
- Sep 1, 2015
- Completion date
- Sep 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 41
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- French National Agency for Research on AIDS and Viral HepatitisLead sponsor
- Hospital AvicenneOverall official - principal investigator
- CHU Kamenge, Bujumbura, BurundiStudy chair
- Hospital AvicenneStudy chair
- Hospital AvicenneCollaborator
- Institut PasteurCollaborator
- CHU Kamenge, Bujumbura, BurundiCollaborator
- CHU TreichvilleOverall official - principal investigator
- University of ParisCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.